Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.58 |
| ▸ | GAA | P10253 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | STAT3 | P40763 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | HTT | P42858 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.47 |
| ▸ | ERN1 | O75460 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30081463 | 1.00 | ALDH1A1 (0.58) | ALDH1A1GAAHPGDKDM4ESTAT3 | |
| SCHEMBL3637204 | 0.80 | ALDH1A1 (0.55) | ALDH1A1GAAHPGDKDM4ESTAT3 | |
| SCHEMBL7891555 | 0.80 | ALDH1A1 (0.54) | ALDH1A1GAAHPGDKDM4ESTAT3 | |
| SCHEMBL6340621 | 0.78 | ALDH1A1 (0.53) | ALDH1A1GAAHPGDKDM4ESTAT3 | |
| SCHEMBL372264 | 0.78 | ALDH1A1 (0.62) | ALDH1A1GAAHPGDKDM4ELMNA | |
| SCHEMBL688007 | 0.78 | TDP1 (0.53) | ALDH1A1GAAHPGDKDM4ESTAT3 | |
| SCHEMBL807146 | 0.78 | TLR8 (0.55) | ALDH1A1GAAHPGDKDM4ELMNA | |
| SCHEMBL11109074 | 0.78 | ALDH1A1 (0.53) | ALDH1A1GAAHPGDKDM4ESTAT3 | |
| SCHEMBL372183 | 0.78 | ALDH1A1 (0.53) | ALDH1A1GAAHPGDKDM4ESTAT3 | |
| SCHEMBL30205213 | 0.78 | ALDH1A1 (0.53) | ALDH1A1GAAHPGDKDM4ESTAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4547658-A1 | WEE1 DEGRADING COMPOUNDS AND USES THEREOF | Bristol-Myers Squibb Company (US) | 2025-05-07 | — | — | EP | disclosed |
| CN-119325469-A | WEE1 degrading compounds and uses thereof | 百时美施贵宝公司 | 2025-01-17 | — | — | CN | disclosed |
| US-20240067632-A1 | WEE1 Degrading Compounds and Uses Thereof | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-02-29 | — | — | US | disclosed |
| WO-2024006881-A1 | WEE1 DEGRADING COMPOUNDS AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-01-04 | — | — | WO | disclosed |
| CN-108602952-A | Novel polyamines, a process for their synthesis and their use for the selective removal of H2S from gaseous effluents containing CO2 | IFP 新能源公司 | 2018-09-28 | — | — | CN | disclosed |
| CN-107836453-A | A kind of Chinese prickly ash moss scavenger composition and its application | 四川国光农化股份有限公司 | 2018-03-27 | — | — | CN | disclosed |
| US-8785628-B2 | Triazine derivatives as kinase inhibitors | UCB PHARMA, S.A. (BE) | 2014-07-22 | — | — | US | disclosed |
| CN-102643587-A | Water-in water type colorful thermal insulation coating and preparation method thereof | SHENZHEN JIADA ENERGY SAVING ENVIRONMENTAL PROT TECHNOLOGY CO LTD | 2012-08-22 | — | — | CN | disclosed |
| US-20120053167-A1 | Triazine Derivatives as Kinase Inhibitors | UCB PHARMA, S.A. (BE) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053167-A1 | Triazine Derivatives as Kinase Inhibitors | MAP3K15, PI4KA, MAP3K20 | ALDH1A1 3504/4885GAA 1302/4885HPGD 3248/4885 |
| US-20240067632-A1 | WEE1 Degrading Compounds and Uses Thereof | WEE1, WEE2, PPME1 | ALDH1A1 3122/4885GAA 817/4885HPGD 2117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.